期刊文献+

新辅助化学疗法对早期巨块型宫颈癌近期疗效分析 被引量:1

Analysis on the Short-term Curative Effect of Neoadjuvant Chemotherapy on the Early-stage Bulky Cervical Carcinoma
原文传递
导出
摘要 目的评价早期巨块型宫颈癌患者术前行新辅助化学疗法的近期疗效。方法回顾分析2005年10月2010年6月收治的Ⅰb~Ⅱa期巨块型宫颈癌患者90例患者的临床资料。根据术前是否行化学疗法将患者分为两组:新辅助化学疗法(neoadjuvant chemotherapy,NACT)组50例,术前予静脉化学疗法或子宫动脉灌注化学疗法治疗1~3个疗程;直接手术组40例,直接行根治性手术。比较新辅助化学疗法前后病灶大小变化,化学疗法不良反应,手术情况及术后病理情况。结果 NACT组总有效率86%(43/50),鳞癌疗效优于腺癌,动脉与静脉化学疗法近期有效率比较,两组差异无统计学意义(P〉0.05)。NACT不良反应小。NACT组术中出血少于直接手术组,两者差异有统计学意义(P〈0.05)。两组深肌层浸润、淋巴结转移、脉管浸润差异均无统计学意义(P〉0.05),NACT组宫旁浸润率低于直接手术组。结论术前NACT对早期巨块型宫颈癌患者近期疗效显著。 Objective To evaluate the short-term curative effect of preoperative neoadjuvant chemotherapy on the early-stage bulky cervical carcinoma.Methods We retrospectively analyzed the clinical data of 70 patients with bulky ⅠB-ⅡA cervical carcinoma treated in our hospital between October 2005 and June 2010.Based on whether the patients received chemotherapy,they were divided into two groups: neoadjuvant chemotherapy group(NACT group) and direct surgery group.In the former group,there were 50 patients who underwent surgery after 1 to 3 cycles of preoperative chemotherapy by uterus artery infusion or intravenous chemoembolization.For the 40 patients in the latter group,direct radical surgery was performed.The size of the tumor before and after chemotherapy,the operation conditions and the postoperative pathological conditions of patients between the two groups were compared and the adverse reactions of neoadjuvant chemotherapy were analyzed as well.Results The total effective rate of NACT group was 86%(43/50).The response to chemotherapy in squamous cell caner was significantly higher than adenocarcinoma.There was no statistical difference between arterial and venous chemotherapy in terms of immediate effect(P0.05).The incidence of adverse reactions of neoadjuvant chemotherapy was low.There was significant difference between the NACT group and the direct surgery group in intraoperative bleeding(P0.05).There were no significant differences between the above two groups in deep muscularis infiltration rate,lymph node metastasis rate and vascular invasion rate.However,the parametrial infiltration rate for the NACT group was lower than that for the direct surgery group.Conclusion Preoperative neoadjuvant chemotherapy on patients with early-stage bulky cervical carcinoma has a remarkable immediate curative effect.
作者 周平
机构地区 宜兴市人民医院
出处 《华西医学》 CAS 2011年第4期517-520,共4页 West China Medical Journal
关键词 宫颈肿瘤 新辅助化疗 近期疗效 Cervical carcinoma Neoadjuvant chemotherapy Immediate curative effect
  • 相关文献

参考文献12

二级参考文献72

  • 1宋水勤,张国楠.宫颈癌新辅助化疗现状[J].实用医院临床杂志,2005,2(2):22-25. 被引量:53
  • 2王平,彭芝兰,张家文,刘辉,张崇淑,曹泽毅.子宫颈癌新辅助化疗中不同化疗途径的疗效比较[J].中华妇产科杂志,2005,40(4):227-230. 被引量:109
  • 3程晓东,吕卫国,叶枫,陈怀增,谢幸.局部晚期子宫颈癌新辅助化疗价值的评估[J].中华妇产科杂志,2006,41(2):95-98. 被引量:66
  • 4凌斌.子宫颈癌诊断与治疗的新进展[J].中国实用妇科与产科杂志,2007,23(1):23-25. 被引量:67
  • 5Micheleti E, Laface B, BianchiE, et al. Continuous infusion of carboplatin during conventional radiothrapy treatment in advanced squamous carcinoma of the eervic uteri ⅡB-ⅢB(UICC) Aphase Ⅰ-Ⅱ and pharmaco kinetic study [J]. Am J Clin Oncol, 1997,20(8) :613 - 620.
  • 6Sugiyama, Nishida T, Hasuo Y, et al. Neoadjuvant Interarterial Clemraotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cancer [J]. Cynecol Oncvol, 1998,69(2) : 130.
  • 7Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002.CA Cancer J Clin,2005,55:74-108.
  • 8Benedetti-Panici P,Scambia G,Greggi S,et al.Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma:a pilot study.Obstet Gynecol,1988,71:344-348.
  • 9Benedetti-Panici P,Greggi S,Colombo A,et al.Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer results from the Italian multicenter randomized study.J Clin Oncol,2002,20:179-188.
  • 10Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada.J Natl Cancer Inst,2000,92:205-216.

共引文献284

同被引文献21

  • 1张颖,林晨,钱海利,郎景和,付明,张雪燕,梁潇,段华,向阳.Ad—TIMP-3转染增加宫颈癌细胞对顺铂的敏感性[J].中华肿瘤杂志,2007,29(1):25-29. 被引量:2
  • 2王蔚文.临床疾病诊断与疗效判断标准[S].北京:科学技术文献出版社,2010:592.
  • 3Vrdoljak E,Hamm W. Current state-of-the-art of con- eomitant chemoradiation in cervical carcinomas [J]. Eur Gynaeeol Oneol,2003,3(6) :475-479.
  • 4Benedet JL,Bender H,Jcm H,et al. FIGO staging vlas- sifications and clinical practice guidelines in Ihc manage- menl of gynecologic cancer. FIGO Committee on Gytwco- logic Ontology [J]. lnt J Gynaecol Obste,2000,70 (2) : 209-262.
  • 5Frei E. Clinical cancer research:ml elutlaliled species [J]. J Cancer, 1982,50(10) : 1979-1992.
  • 6Eeke TH,Schlechte HH,Sehiemenz K,et al. TP53 gent, mutations in prostate cancer progression [J]. Anticanccr Res, 2010,30(5) : 1579-1586.
  • 7Swisher SG,Roth JA, Komaki R,et al. Induction of p53- regulated genes and tumor regression in hmg cancer pa- tients after intratumoral delivery of adenoviral p53 (IN- GN 201) and radiation therapy [J]. Clin Cancer Res, 2003,9( 1):93-101.
  • 8LIU YL,Zheng XL,Liu FM. The mechanism and in- hibitory effect of recombinant human P53 adenovirus in- jection combined with paclilaxel on human cervical can- cer cell HeLa[ J]. Eur European Review for Melical an Pharmacological Sciences,2015, 19(6):1037-1042.
  • 9Fontanini G,Boldrini L,Vignati S,et al. Bei-2 anti P53 regulate Vascular endothelial grolh factor(VEGF) medi- ated angiogen-esis in non-small-cell lung carcinoma [J]. Eur J Cancer, 1998,34(5) :718-723.
  • 10刘婷婷,孔为民,孙立新,张卫华,李静,韩超.AD-p53及联合顺铂治疗卵巢癌裸鼠腹腔移植瘤及腹水的实验研究[J].实用妇产科杂志,2010,26(6):429-432. 被引量:3

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部